semaglutide ckd without diabetes just got FDA-approved for kidney disease. This changes everything., January 2025. The FDA approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in Post hoc analysis of SUSTAIN

These symptoms are often mild to moderate and can decrease over time

Do not stop the medication without medical guidance, as this could affect your diabetes control

doi: 10.1136/gut.2009.200063 Jung JJ, Naimark DM, Behman R, Grantcharov TP (2018) Approach to asymptomatic paraesophageal hernia: watchful waiting or elective laparoscopic hernia repair

Two or three variable observations were compared using the paired-samples t test or repeated one-way ANOVA for normally distributed data and the Wilcoxon test or Friedman's test for non-normally distributed data

After 4 weeks, most patients report measurable appetite reduction